武汉大学学报(医学版)
武漢大學學報(醫學版)
무한대학학보(의학판)
Wuhan University(Medical Edition)
2001年
2期
178-180
,共3页
张帆%陈惠祯%刘诗权%杨庆忆%侯汉英
張帆%陳惠禎%劉詩權%楊慶憶%侯漢英
장범%진혜정%류시권%양경억%후한영
卵巢肿瘤%谷胱甘肽转移酶类%药物疗法
卵巢腫瘤%穀胱甘肽轉移酶類%藥物療法
란소종류%곡광감태전이매류%약물요법
目的:了解卵巢癌中谷胱甘肽S-转移酶-π(GST-π)的表达与化疗的关系。方法:运用免疫组织化学技术对74例术前未治疗的上皮性卵巢癌进行GST-π检测。结果:74例卵巢癌中GST-π阳性55例,阳性率为74.3%。卵巢癌中GST-π的表达与病理类型无相关性(P>0.05)。对首次术后有残余癌的27例患者行化疗反应评价,GST-π阳性者与阴性者的化疗反应率为13.3%及83.3%,两者间差异有显著性(P<0.01)。GST-π阳性对耐药的预测值为86.7%,GST-π阴性对化疗反应的预测值为83.3%。结论:未治疗卵巢癌中存在着由GST-π介导的内在性耐药机制,GST-π的表达能较好地预测化疗反应。
目的:瞭解卵巢癌中穀胱甘肽S-轉移酶-π(GST-π)的錶達與化療的關繫。方法:運用免疫組織化學技術對74例術前未治療的上皮性卵巢癌進行GST-π檢測。結果:74例卵巢癌中GST-π暘性55例,暘性率為74.3%。卵巢癌中GST-π的錶達與病理類型無相關性(P>0.05)。對首次術後有殘餘癌的27例患者行化療反應評價,GST-π暘性者與陰性者的化療反應率為13.3%及83.3%,兩者間差異有顯著性(P<0.01)。GST-π暘性對耐藥的預測值為86.7%,GST-π陰性對化療反應的預測值為83.3%。結論:未治療卵巢癌中存在著由GST-π介導的內在性耐藥機製,GST-π的錶達能較好地預測化療反應。
목적:료해란소암중곡광감태S-전이매-π(GST-π)적표체여화료적관계。방법:운용면역조직화학기술대74례술전미치료적상피성란소암진행GST-π검측。결과:74례란소암중GST-π양성55례,양성솔위74.3%。란소암중GST-π적표체여병리류형무상관성(P>0.05)。대수차술후유잔여암적27례환자행화료반응평개,GST-π양성자여음성자적화료반응솔위13.3%급83.3%,량자간차이유현저성(P<0.01)。GST-π양성대내약적예측치위86.7%,GST-π음성대화료반응적예측치위83.3%。결론:미치료란소암중존재착유GST-π개도적내재성내약궤제,GST-π적표체능교호지예측화료반응。
To determine the relationship between the expression of glutathione S-transferase-π (GST-π) and the response to chemotherapy in ovarian cancer.Methods:Expression of GST-π was immunohistochemically studied in paraffin sections from 74 patients with ovarian cancer who had not received any chemotherapy before surgery.Results:GST-π immunoreactivity was present in 55 (74.3%) of the tumor tissues and was not associated with histopathologic types.Of 27 clinically measurable lesions after surgery,the response rate to chemotherapy in GST-π-positive group (13.3,2/15) was significantly lower than that in the GST-π-negative group (83.3,10/12;P<0.01).The predictive value of positive GST-π staining for drug resistance was 86.7%,and that of negative staining for objective responders was 83.3%.Conclusion:The data suggest that GST-π expression in tumor cells is related to drug resistance of the patients with epithelial ovarian cancer and is a useful marker of response to chemotherapy.